data_2n07_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n07 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.671 0.272 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.706 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.706 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.578 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.578 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.551 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.431 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.431 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . 0.531 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.491 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.088 0.47 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.495 ' CZ ' HD13 ' X' ' 15' ' ' ILE . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.495 HD13 ' CZ ' ' X' ' 8' ' ' PHE . 61.5 mt . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' X' ' 9' ' ' ASN . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' X' ' 6' ' ' PRO . 50.2 m-80 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 62.5 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . 0.416 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.937 0.399 . . . . 0.0 111.759 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . 0.416 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.452 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.452 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . 0.41 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.092 0.473 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.103 0.478 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . 0.583 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.583 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.445 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.445 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.414 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . 0.401 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . 0.509 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . 0.429 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.413 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.836 0.351 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.509 ' HB3' ' CB ' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . 0.407 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.561 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 78.6 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.453 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.453 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . 0.478 ' OE2' HG13 ' X' ' 15' ' ' ILE . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . 0.478 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.929 0.395 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 5' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 6' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.443 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 41.6 t60 -78.81 38.13 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.322 0.582 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.651 ' HB2' ' HA ' ' X' ' 20' ' ' ALA . 47.7 m -70.5 -5.41 28.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.24 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.443 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -65.91 -48.53 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 87.5 m -76.52 -43.16 40.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.66 -64.18 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.498 -0.382 . . . . 0.0 112.778 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.14 38.13 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.57 137.66 12.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.51 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . 0.651 ' HA ' ' HB2' ' X' ' 3' ' ' CYS . . . -64.98 -25.73 67.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.74 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.93 -12.05 40.8 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.888 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.537 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.469 0 CA-C-O 120.727 0.07 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -83.5 -6.34 59.43 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.353 -0.498 . . . . 0.0 110.609 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.13 -4.42 32.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.577 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -72.13 -43.03 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.434 ' HB3' ' O ' ' X' ' 19' ' ' ALA . 56.4 m -146.81 -52.11 0.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . 0.577 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . 54.47 37.39 60.31 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.679 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.76 -42.81 1.42 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' X' ' 16' ' ' CYS . . . -68.06 126.28 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.699 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.1 49.05 1.05 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.799 0.333 . . . . 0.0 111.623 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.37 -52.06 5.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.875 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.703 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -145.01 37.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t -63.04 -22.97 67.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.234 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.706 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.706 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.34 -39.79 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -68.27 -45.12 74.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.45 97.66 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.482 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.65 44.41 2.94 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.864 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.61 -51.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.81 0.338 . . . . 0.0 110.217 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.57 32.35 18.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.114 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.39 47.29 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.937 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.688 179.56 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.667 ' HD2' ' HB2' ' X' ' 8' ' ' PHE . 66.4 t60 -78.0 17.97 0.54 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.021 0.439 . . . . 0.0 110.502 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' X' ' 1' ' ' GLY . 18.6 m -64.87 -21.19 66.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.656 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.667 ' HB2' ' HD2' ' X' ' 2' ' ' HIS . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.578 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.578 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt -57.5 -45.04 85.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.97 -44.33 61.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.092 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.66 1.54 Allowed Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 113.224 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.34 -33.02 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.4 121.09 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.87 92.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.143 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.04 34.19 2.61 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.959 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.877 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.963 0.202 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.97 -5.45 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.681 0.277 . . . . 0.0 110.443 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m -61.18 -20.21 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.551 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' X' ' 17' ' ' GLY . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.551 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.69 ' HA ' ' HA2' ' X' ' 17' ' ' GLY . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.431 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.431 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt -68.75 -38.29 78.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 p -158.17 -44.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.405 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . 0.69 ' HA2' ' HA ' ' X' ' 13' ' ' PRO . . . 81.1 -34.32 2.4 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.411 -0.899 . . . . 0.0 114.375 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.98 110.92 0.43 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.454 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.35 1.06 . . . . 0.0 113.476 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.24 -45.77 0.56 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.674 0.789 . . . . 0.0 112.082 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.16 44.28 5.08 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.83 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.487 ' C ' ' H ' ' X' ' 4' ' ' SER . 66.6 m-70 -151.81 38.97 0.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.479 0.18 . . . . 0.0 110.609 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m -72.77 22.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 4' ' ' SER . . . . . 0.487 ' H ' ' C ' ' X' ' 2' ' ' HIS . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . 0.531 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.73 -43.22 86.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.66 -43.89 95.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.47 -43.93 95.97 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.863 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -32.86 85.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.067 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.71 -3.83 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.5 12.06 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.597 0.56 . . . . 0.0 111.41 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.38 43.73 30.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.999 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.276 -0.329 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -81.96 23.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 109.912 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.651 ' HB3' ' HA ' ' X' ' 20' ' ' ALA . 2.8 m -63.64 -21.44 66.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.049 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.491 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.491 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.511 ' HA ' ' HA3' ' X' ' 17' ' ' GLY . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt -68.32 -53.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' X' ' 19' ' ' ALA . 25.9 p -171.46 46.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.872 0.367 . . . . 0.0 111.204 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' X' ' 13' ' ' PRO . . . -66.98 -51.29 40.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.187 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.23 -46.61 7.45 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' X' ' 16' ' ' CYS . . . -85.92 65.09 8.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' X' ' 3' ' ' CYS . . . -68.94 67.35 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.603 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 48.44 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.695 -179.883 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.776 0.098 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -118.52 32.21 6.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.174 0.511 . . . . 0.0 109.78 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t -69.55 -11.53 60.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.495 ' CZ ' HD13 ' X' ' 15' ' ' ILE . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.625 ' HA ' ' HB2' ' X' ' 19' ' ' ALA . 61.5 mt -61.08 -48.61 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.51 -36.22 52.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.455 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -45.0 96.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.915 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.92 64.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.241 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . 0.625 ' HB2' ' HA ' ' X' ' 15' ' ' ILE . . . -153.57 -43.69 0.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.534 0.206 . . . . 0.0 110.625 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.89 38.17 21.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.364 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.69 -29.43 73.84 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.355 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.67 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 CA-C-O 120.998 0.221 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -158.72 35.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m -61.17 -18.12 56.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.858 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' X' ' 9' ' ' ASN . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' X' ' 6' ' ' PRO . 50.2 m-80 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.6 ' HA ' ' HB1' ' X' ' 19' ' ' ALA . 62.5 mt -65.13 -49.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.14 -30.62 69.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.277 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.63 -46.62 38.33 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.681 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.83 48.65 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.398 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . 0.6 ' HB1' ' HA ' ' X' ' 15' ' ' ILE . . . -150.65 49.24 0.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.418 0.627 . . . . 0.0 109.762 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.39 129.86 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.28 -45.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.546 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' X' ' 4' ' ' SER . 59.7 m-70 -150.06 29.33 0.73 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.416 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m -79.48 30.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.759 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 4' ' ' SER . . . . . 0.401 ' H ' ' C ' ' X' ' 2' ' ' HIS . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.549 ' O ' ' HA2' ' X' ' 17' ' ' GLY . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.638 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.452 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.452 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt -84.09 -48.47 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' X' ' 20' ' ' ALA . 3.6 p -167.37 66.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.257 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . 0.638 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . -72.63 55.81 1.67 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.538 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.39 -49.08 0.46 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.145 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.13 166.15 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' X' ' 16' ' ' CYS . . . -165.79 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.31 34.33 41.19 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.054 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -151.61 42.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.951 0.405 . . . . 0.0 110.025 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.41 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m -77.88 41.1 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.225 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.612 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.8 -47.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 58.1 m -66.45 -38.98 88.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.998 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 -42.8 7.61 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.436 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 -52.05 6.31 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.841 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.13 -49.33 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.838 0.319 . . . . 0.0 111.438 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.53 -75.29 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.429 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.34 47.72 3.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.051 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.866 -179.598 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.894 -0.483 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' X' ' 4' ' ' SER . 31.6 t-80 -153.13 38.84 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m -77.71 29.63 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 4' ' ' SER . . . . . 0.433 ' H ' ' C ' ' X' ' 2' ' ' HIS . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . 0.583 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.583 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.445 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.445 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt -65.1 -48.18 84.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 84.9 m -64.3 -42.11 96.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.75 -42.37 93.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.362 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.6 89.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.728 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -44.25 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.74 25.78 10.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.229 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.45 52.77 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.775 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 179.692 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.417 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 14.3 t-160 -81.55 44.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.305 . . . . 0.0 110.702 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m -63.95 -16.86 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.366 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.414 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.29 -53.28 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.731 ' HA ' ' HA3' ' X' ' 21' ' ' GLY . 62.5 m -79.47 -36.39 38.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.97 -53.72 2.16 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.918 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.41 -39.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.36 141.73 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.96 39.35 20.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.826 0.704 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . 0.731 ' HA3' ' HA ' ' X' ' 16' ' ' CYS . . . -69.96 -29.48 70.76 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.487 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.409 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-O 120.89 0.161 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -74.21 44.87 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.758 0.423 . . . . 0.0 111.333 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m -66.8 -12.21 58.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . 0.401 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.461 HG21 ' HA2' ' X' ' 22' ' ' GLY . 34.1 mt -61.08 -56.18 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.38 -32.59 66.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.811 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.12 -38.93 96.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.855 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.25 78.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.2 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.9 -49.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.889 0.875 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 119.03 13.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.124 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.61 40.25 47.06 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.055 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' X' ' 15' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.414 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.505 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -162.24 41.3 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.509 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m -73.17 44.94 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.405 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . 0.429 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.413 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.509 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.413 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt -68.57 -47.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 m -64.55 -41.87 96.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.265 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.13 58.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.695 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.87 57.29 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.786 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.12 38.08 28.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.26 73.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.646 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.66 45.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.803 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' X' ' 5' ' ' ASP . 21.2 t-80 -169.55 34.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.473 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.42 -12.39 61.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.389 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.509 ' HB3' ' CB ' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . 0.407 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.561 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 59.8 mt -79.64 -59.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' X' ' 20' ' ' ALA . 58.2 m -84.28 15.49 3.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.12 -46.02 5.73 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.83 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 42.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.235 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.05 -50.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . 0.735 ' HA ' ' HA ' ' X' ' 16' ' ' CYS . . . 68.93 -63.03 0.38 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.77 -32.44 1.04 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.691 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' X' ' 20' ' ' ALA . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.466 ' CD2' ' HB2' ' X' ' 5' ' ' ASP . 16.5 t-160 -79.86 19.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.508 -0.407 . . . . 0.0 110.209 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.426 ' H ' ' C ' ' X' ' 1' ' ' GLY . 22.3 m -66.44 -17.81 65.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.776 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.466 ' HB2' ' CD2' ' X' ' 2' ' ' HIS . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . 0.526 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.57 -57.46 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 77.2 m -63.63 -35.61 81.1 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.83 -40.37 64.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.6 -53.14 6.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.876 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.84 124.11 0.64 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.86 -46.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.452 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.18 -56.35 3.62 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.824 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.132 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.85 30.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 78.6 m -81.31 44.07 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.346 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . 0.553 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.453 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.453 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt -67.42 -48.28 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 77.2 m -66.56 -36.68 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.34 44.31 2.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.939 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.59 -46.13 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.61 53.8 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 111.032 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.24 131.44 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.95 32.84 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.178 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.784 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.799 179.755 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -76.91 49.55 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -73.83 50.11 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . 0.478 ' OE2' HG13 ' X' ' 15' ' ' ILE . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . 0.478 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt -67.52 -54.79 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -69.82 -38.46 76.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.441 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.03 46.35 3.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.259 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.87 -56.21 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.29 -47.36 13.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.02 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.387 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.88 -37.59 50.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.915 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.347 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' X' X ' 1' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 121.151 0.306 . . . . 0.0 112.723 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 2' ' ' HIS . . . . . 0.494 ' HB3' ' CD2' ' X' ' 8' ' ' PHE . 20.4 t-160 -77.46 40.16 0.28 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.33 -0.512 . . . . 0.0 110.529 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 3' ' ' CYS . . . . . 0.418 ' H ' ' C ' ' X' ' 1' ' ' GLY . 28.6 m -68.39 -14.65 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 5' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 6' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 8' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' X' ' 2' ' ' HIS . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.65 -34.58 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -45.68 91.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.717 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.79 62.13 3.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.984 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.44 -41.6 93.38 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.637 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.16 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.144 0.497 . . . . 0.0 110.474 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.62 118.9 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.823 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.74 -64.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.729 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.75 179.428 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.671 0.272 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.712 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 7' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.596 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.596 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.436 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 7' ' ' ARG . . . . . 0.526 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.088 0.47 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.416 ' HZ ' HD12 ' X' ' 15' ' ' ILE . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.416 HD12 ' HZ ' ' X' ' 8' ' ' PHE . 62.5 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 3' ' ' CYS . . . . . 0.424 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.937 0.399 . . . . 0.0 111.759 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.482 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 3' ' ' CYS . . . . . 0.421 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.092 0.473 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.103 0.478 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 7' ' ' ARG . . . . . 0.599 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.448 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 13' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' X' ' 6' ' ' PRO . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.41 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' X' X ' 13' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' X' X ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 7' ' ' ARG . . . . . 0.422 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.417 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 10' ' ' TYR . . . . . 0.402 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 13' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.836 0.351 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 7' ' ' ARG . . . . . 0.412 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' X' ' 15' ' ' ILE . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' X' ' 14' ' ' GLU . 59.8 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 11' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' X' X ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 78.6 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.464 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.464 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' X' X ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' X' ' 14' ' ' GLU . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' X' X ' 15' ' ' ILE . . . . . 0.483 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.929 0.395 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 5' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 6' ' ' PRO . . . . . 0.469 ' HA ' HD22 ' X' ' 9' ' ' ASN . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 9' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' X' ' 6' ' ' PRO . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.446 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 41.6 t60 -78.81 38.13 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.322 0.582 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.667 ' HB2' ' HA ' ' X' ' 20' ' ' ALA . 47.7 m -70.5 -5.41 28.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.24 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -65.91 -48.53 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 87.5 m -76.52 -43.16 40.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.66 -64.18 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.498 -0.382 . . . . 0.0 112.778 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.14 38.13 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.57 137.66 12.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.51 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 20' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' X' ' 3' ' ' CYS . . . -64.98 -25.73 67.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.74 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.93 -12.05 40.8 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.888 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.537 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.469 0 CA-C-O 120.727 0.07 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -83.5 -6.34 59.43 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.353 -0.498 . . . . 0.0 110.609 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.13 -4.42 32.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.591 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -72.13 -43.03 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' X' ' 19' ' ' ALA . 56.4 m -146.81 -52.11 0.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 17' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . 54.47 37.39 60.31 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.679 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.76 -42.81 1.42 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 19' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' X' ' 16' ' ' CYS . . . -68.06 126.28 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.699 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.1 49.05 1.05 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.799 0.333 . . . . 0.0 111.623 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.37 -52.06 5.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.875 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.703 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -145.01 37.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t -63.04 -22.97 67.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.234 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.712 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.34 -39.79 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -68.27 -45.12 74.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.45 97.66 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.482 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.65 44.41 2.94 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.864 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.61 -51.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.81 0.338 . . . . 0.0 110.217 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.57 32.35 18.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.114 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.39 47.29 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.937 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.688 179.56 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' X' X ' 1' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.414 ' ND1' ' HB2' ' X' ' 8' ' ' PHE . 17.4 t-80 -78.0 17.97 0.54 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.021 0.439 . . . . 0.0 110.502 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' X' ' 1' ' ' GLY . 18.6 m -64.87 -21.19 66.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.656 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 7' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.414 ' HB2' ' ND1' ' X' ' 2' ' ' HIS . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.596 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.596 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt -57.5 -45.04 85.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.97 -44.33 61.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.092 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.66 1.54 Allowed Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 113.224 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.34 -33.02 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.4 121.09 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.87 92.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.143 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.04 34.19 2.61 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.959 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.877 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.963 0.202 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.97 -5.45 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.681 0.277 . . . . 0.0 110.443 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m -61.18 -20.21 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' X' ' 17' ' ' GLY . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.7 ' HA ' ' HA2' ' X' ' 17' ' ' GLY . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.436 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt -68.75 -38.29 78.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' X' ' 20' ' ' ALA . 1.7 p -158.17 -44.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.405 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 17' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' X' ' 13' ' ' PRO . . . 81.1 -34.32 2.4 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.411 -0.899 . . . . 0.0 114.375 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.98 110.92 0.43 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.454 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.35 1.06 . . . . 0.0 113.476 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' X' ' 16' ' ' CYS . . . 69.24 -45.77 0.56 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.674 0.789 . . . . 0.0 112.082 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.16 44.28 5.08 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.83 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' X' ' 4' ' ' SER . 66.6 m-70 -151.81 38.97 0.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.479 0.18 . . . . 0.0 110.609 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m -72.77 22.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 4' ' ' SER . . . . . 0.452 ' H ' ' C ' ' X' ' 2' ' ' HIS . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 7' ' ' ARG . . . . . 0.526 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.73 -43.22 86.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.66 -43.89 95.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.47 -43.93 95.97 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.863 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -32.86 85.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.067 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.71 -3.83 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.5 12.06 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.597 0.56 . . . . 0.0 111.41 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.38 43.73 30.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.999 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' X' X ' 1' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.276 -0.329 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -81.96 23.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 109.912 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.658 ' HB3' ' HA ' ' X' ' 20' ' ' ALA . 2.8 m -63.64 -21.44 66.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.049 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.52 ' HA ' ' HA3' ' X' ' 17' ' ' GLY . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt -68.32 -53.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' X' ' 19' ' ' ALA . 25.9 p -171.46 46.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.872 0.367 . . . . 0.0 111.204 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 17' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' X' ' 13' ' ' PRO . . . -66.98 -51.29 40.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.187 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.23 -46.61 7.45 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' X' ' 16' ' ' CYS . . . -85.92 65.09 8.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 20' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' X' ' 3' ' ' CYS . . . -68.94 67.35 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.603 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 48.44 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.695 -179.883 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.776 0.098 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -118.52 32.21 6.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.174 0.511 . . . . 0.0 109.78 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t -69.55 -11.53 60.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.862 ' HA ' ' HB3' ' X' ' 19' ' ' ALA . 61.5 mt -61.08 -48.61 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.51 -36.22 52.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.455 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -45.0 96.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.915 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.92 64.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.241 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 19' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' X' ' 15' ' ' ILE . . . -153.57 -43.69 0.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.534 0.206 . . . . 0.0 110.625 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.89 38.17 21.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.364 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' X' X ' 21' ' ' GLY . . . . . 0.458 ' H ' HG23 ' X' ' 15' ' ' ILE . . . -67.69 -29.43 73.84 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.355 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.67 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 CA-C-O 120.998 0.221 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -158.72 35.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m -61.17 -18.12 56.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.858 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.416 ' HZ ' HD12 ' X' ' 15' ' ' ILE . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' X' ' 19' ' ' ALA . 62.5 mt -65.13 -49.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.14 -30.62 69.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.277 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.63 -46.62 38.33 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.681 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.83 48.65 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.398 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 19' ' ' ALA . . . . . 1.001 ' HB3' ' HA ' ' X' ' 15' ' ' ILE . . . -150.65 49.24 0.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.418 0.627 . . . . 0.0 109.762 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.39 129.86 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.28 -45.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.546 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -150.06 29.33 0.73 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.424 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m -79.48 30.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.759 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.556 ' O ' ' HA2' ' X' ' 17' ' ' GLY . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.642 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.482 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt -84.09 -48.47 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' X' ' 20' ' ' ALA . 3.6 p -167.37 66.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.257 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 17' ' ' GLY . . . . . 0.642 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . -72.63 55.81 1.67 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.538 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.39 -49.08 0.46 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.145 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.13 166.15 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 20' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' X' ' 16' ' ' CYS . . . -165.79 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.31 34.33 41.19 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.054 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -151.61 42.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.951 0.405 . . . . 0.0 110.025 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.421 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m -77.88 41.1 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.225 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.8 -47.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 58.1 m -66.45 -38.98 88.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.998 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 -42.8 7.61 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.436 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 -52.05 6.31 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.841 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.13 -49.33 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.838 0.319 . . . . 0.0 111.438 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.53 -75.29 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.429 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.34 47.72 3.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.051 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.866 -179.598 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.894 -0.483 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' X' ' 4' ' ' SER . 31.6 t-80 -153.13 38.84 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m -77.71 29.63 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 4' ' ' SER . . . . . 0.401 ' H ' ' C ' ' X' ' 2' ' ' HIS . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 7' ' ' ARG . . . . . 0.599 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.448 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt -65.1 -48.18 84.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 84.9 m -64.3 -42.11 96.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.75 -42.37 93.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.362 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.6 89.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.728 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -44.25 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.74 25.78 10.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.229 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.45 52.77 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.775 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 179.692 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 14.3 t-160 -81.55 44.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.305 . . . . 0.0 110.702 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m -63.95 -16.86 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.366 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.425 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.29 -53.28 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.758 ' HA ' ' HA3' ' X' ' 21' ' ' GLY . 62.5 m -79.47 -36.39 38.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.97 -53.72 2.16 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.918 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.41 -39.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.36 141.73 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.96 39.35 20.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.826 0.704 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' X' X ' 21' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' X' ' 16' ' ' CYS . . . -69.96 -29.48 70.76 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.487 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.409 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-O 120.89 0.161 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -74.21 44.87 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.758 0.423 . . . . 0.0 111.333 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m -66.8 -12.21 58.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' X' ' 6' ' ' PRO . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.41 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.588 HG22 ' HA2' ' X' ' 22' ' ' GLY . 34.1 mt -61.08 -56.18 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.38 -32.59 66.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.811 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.12 -38.93 96.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.855 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.25 78.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.2 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.9 -49.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.889 0.875 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 119.03 13.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.124 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.61 40.25 47.06 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.055 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' X' X ' 22' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' X' ' 15' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.414 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.505 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -162.24 41.3 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m -73.17 44.94 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.405 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 7' ' ' ARG . . . . . 0.422 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.417 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 10' ' ' TYR . . . . . 0.402 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 13' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt -68.57 -47.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 m -64.55 -41.87 96.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.265 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.13 58.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.695 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.87 57.29 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.786 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.12 38.08 28.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.26 73.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.646 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.66 45.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.803 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' X' ' 5' ' ' ASP . 21.2 t-80 -169.55 34.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.473 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.42 -12.39 61.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.389 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 7' ' ' ARG . . . . . 0.412 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' X' ' 15' ' ' ILE . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' X' ' 14' ' ' GLU . 59.8 mt -79.64 -59.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.722 ' HA ' ' HA ' ' X' ' 20' ' ' ALA . 58.2 m -84.28 15.49 3.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.12 -46.02 5.73 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.83 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 42.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.235 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.05 -50.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 20' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' X' ' 16' ' ' CYS . . . 68.93 -63.03 0.38 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.77 -32.44 1.04 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.691 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' X' X ' 22' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' X' ' 20' ' ' ALA . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' X' ' 5' ' ' ASP . 16.5 t-160 -79.86 19.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.508 -0.407 . . . . 0.0 110.209 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 22.3 m -66.44 -17.81 65.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.776 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.486 ' HB2' ' CD2' ' X' ' 2' ' ' HIS . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 11' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.57 -57.46 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 77.2 m -63.63 -35.61 81.1 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.83 -40.37 64.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.6 -53.14 6.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.876 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.84 124.11 0.64 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.86 -46.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.452 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.18 -56.35 3.62 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.824 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.132 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.85 30.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 78.6 m -81.31 44.07 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.346 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.562 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.464 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.464 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt -67.42 -48.28 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 16' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 77.2 m -66.56 -36.68 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.34 44.31 2.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.939 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.59 -46.13 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.61 53.8 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 111.032 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.24 131.44 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.95 32.84 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.178 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.784 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.799 179.755 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -76.91 49.55 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -73.83 50.11 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' X' ' 14' ' ' GLU . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' X' X ' 15' ' ' ILE . . . . . 0.483 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt -67.52 -54.79 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -69.82 -38.46 76.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.441 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.03 46.35 3.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.259 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.87 -56.21 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.29 -47.36 13.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.02 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.387 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.88 -37.59 50.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.915 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.347 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 121.151 0.306 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' X' X ' 2' ' ' HIS . . . . . 0.496 ' HB3' ' CD2' ' X' ' 8' ' ' PHE . 20.4 t-160 -77.46 40.16 0.28 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.33 -0.512 . . . . 0.0 110.529 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 28.6 m -68.39 -14.65 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.409 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 5' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 6' ' ' PRO . . . . . 0.469 ' HA ' HD22 ' X' ' 9' ' ' ASN . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 8' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' X' ' 2' ' ' HIS . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 9' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' X' ' 6' ' ' PRO . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.65 -34.58 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -45.68 91.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.717 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.79 62.13 3.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.984 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.44 -41.6 93.38 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.637 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.16 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.144 0.497 . . . . 0.0 110.474 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.62 118.9 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.823 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.74 -64.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.729 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.75 179.428 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 47.7 m . . . . . 0 N--CA 1.462 0.156 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 CA--C 1.526 0.031 0 CA-C-O 120.671 0.272 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.712 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.596 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.596 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.436 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . 0.526 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.088 0.47 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 61.5 mt . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' X' ' 9' ' ' ASN . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.416 ' HZ ' HD12 ' X' ' 15' ' ' ILE . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' X' ' 6' ' ' PRO . 50.2 m-80 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.416 HD12 ' HZ ' ' X' ' 8' ' ' PHE . 62.5 mt . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . 0.424 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.937 0.399 . . . . 0.0 111.759 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.482 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . 0.421 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 121.092 0.473 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.421 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.103 0.478 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . 0.599 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.448 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' X' ' 6' ' ' PRO . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.41 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 34.1 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . 0.422 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.417 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . 0.402 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.836 0.351 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . 0.412 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' X' ' 15' ' ' ILE . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' X' ' 14' ' ' GLU . 59.8 mt . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 22.3 m . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 120.81 0.338 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 78.6 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.464 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.464 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' X' ' 14' ' ' GLU . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . 0.483 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.46 0.063 0 CA-C-O 120.929 0.395 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 5' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 6' ' ' PRO . . . . . 0.469 ' HA ' HD22 ' X' ' 9' ' ' ASN . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 9' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' X' ' 6' ' ' PRO . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.702 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.446 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 41.6 t60 -78.81 38.13 0.32 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.322 0.582 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.667 ' HB2' ' HA ' ' X' ' 20' ' ' ALA . 47.7 m -70.5 -5.41 28.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.24 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -14.56 60.28 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.67 0.748 . . . . 0.0 109.239 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 9.7 t70 -84.72 129.62 56.23 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.6 -35.24 60.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.696 2.264 . . . . 0.0 111.955 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -74.42 -47.38 34.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.567 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -53.93 -39.24 65.7 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.592 0.558 . . . . 0.0 112.301 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -62.06 -41.36 98.07 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.989 0.423 . . . . 0.0 110.722 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -77.35 -39.83 46.17 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.432 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -65.28 -40.54 94.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.049 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -137.87 75.11 43.14 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.981 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.74 -27.26 31.91 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.874 2.382 . . . . 0.0 112.238 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -39.01 72.78 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 mt -65.91 -48.53 81.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.387 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 87.5 m -76.52 -43.16 40.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.768 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.66 -64.18 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.498 -0.382 . . . . 0.0 112.778 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.14 38.13 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.57 137.66 12.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.715 0.293 . . . . 0.0 110.51 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' X' ' 3' ' ' CYS . . . -64.98 -25.73 67.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.74 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.93 -12.05 40.8 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.888 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.537 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.469 0 CA-C-O 120.727 0.07 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -83.5 -6.34 59.43 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.353 -0.498 . . . . 0.0 110.609 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 74.7 m -73.13 -4.42 32.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.752 0.311 . . . . 0.0 111.718 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.6 t -73.97 -22.75 59.51 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -82.75 124.66 76.99 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.355 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.63 -31.33 94.45 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 123.099 2.532 . . . . 0.0 112.451 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -52.39 61.98 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.555 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -57.27 -36.3 70.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -67.65 -43.69 79.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.315 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -72.25 -46.06 57.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 110.954 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -68.42 -24.39 64.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.4 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -141.16 83.25 13.94 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.456 0.646 . . . . 0.0 111.577 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.591 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 70.3 Cg_endo -75.07 -18.39 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.131 2.554 . . . . 0.0 112.798 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.85 -36.83 49.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 66.8 mt -72.13 -43.03 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' X' ' 19' ' ' ALA . 56.4 m -146.81 -52.11 0.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . 0.591 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . 54.47 37.39 60.31 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 113.679 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 126.76 -42.81 1.42 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' X' ' 16' ' ' CYS . . . -68.06 126.28 29.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.699 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.1 49.05 1.05 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.799 0.333 . . . . 0.0 111.623 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.37 -52.06 5.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.875 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.703 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.578 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -145.01 37.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 8.0 t -63.04 -22.97 67.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.234 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -74.51 52.94 0.52 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.825 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -164.78 117.51 0.95 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.88 -32.84 79.51 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.052 2.502 . . . . 0.0 112.483 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -68.6 -44.32 74.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.145 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.712 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.5 t80 -63.92 -32.85 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.592 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -62.01 -29.08 70.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.527 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -93.41 -44.97 8.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.329 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.712 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.4 OUTLIER -76.81 -32.54 57.68 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -142.09 59.98 10.06 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.8 -30.04 77.38 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.12 1.88 . . . . 0.0 110.343 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -49.02 71.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.462 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.34 -39.79 83.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.197 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -68.27 -45.12 74.0 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.27 -44.45 97.66 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.482 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.65 44.41 2.94 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.864 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.61 -51.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.81 0.338 . . . . 0.0 110.217 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.57 32.35 18.96 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.114 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.39 47.29 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.937 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.523 0 C-N-CA 120.128 -1.034 . . . . 0.0 112.688 179.56 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.667 ' HD2' ' HB2' ' X' ' 8' ' ' PHE . 66.4 t60 -78.0 17.97 0.54 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.021 0.439 . . . . 0.0 110.502 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.409 ' H ' ' C ' ' X' ' 1' ' ' GLY . 18.6 m -64.87 -21.19 66.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.656 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -64.25 -21.61 66.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 109.723 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 20.9 t70 -92.29 125.25 57.01 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.576 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 13.3 Cg_endo -56.75 -33.55 94.35 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.456 2.771 . . . . 0.0 113.824 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' X' ' 7' ' ' ARG . 5.4 mpt_? -64.47 -48.32 75.69 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.997 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.667 ' HB2' ' HD2' ' X' ' 2' ' ' HIS . 20.6 t80 -58.43 -38.69 77.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.815 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -61.14 -38.01 84.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -78.98 -41.11 29.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.47 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -66.22 -50.8 62.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.56 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -137.51 79.13 36.28 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.71 -21.39 25.31 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 111.673 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.596 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -65.0 -49.77 68.92 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.438 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.596 HG13 ' OE1' ' X' ' 14' ' ' GLU . 20.7 mt -57.5 -45.04 85.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.482 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.97 -44.33 61.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.092 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.21 -49.66 1.54 Allowed Glycine 0 CA--C 1.521 0.418 0 CA-C-N 116.351 -0.386 . . . . 0.0 113.224 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.34 -33.02 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.4 121.09 15.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.962 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.87 92.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.143 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.04 34.19 2.61 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.959 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.452 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.877 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 CA-C-O 120.963 0.202 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.97 -5.45 59.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.681 0.277 . . . . 0.0 110.443 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 63.5 m -61.18 -20.21 62.48 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 7.5 m -63.62 -27.28 69.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.402 0.62 . . . . 0.0 109.643 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 52.0 t0 -84.82 122.24 74.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.89 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.6 Cg_endo -56.19 -27.36 65.45 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 123.303 2.669 . . . . 0.0 112.55 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -63.09 -44.32 96.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 16.7 t80 -67.07 -26.69 66.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.554 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' X' ' 17' ' ' GLY . 4.3 m120 -69.14 -36.25 77.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.043 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -76.77 -44.35 33.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.086 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.565 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -78.77 -19.85 51.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.653 -178.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -137.21 72.5 52.63 Favored Pre-proline 0 C--O 1.236 0.389 0 CA-C-O 121.328 0.585 . . . . 0.0 112.271 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.7 ' HA ' ' HA2' ' X' ' 17' ' ' GLY . 45.1 Cg_endo -68.36 -31.69 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.77 2.313 . . . . 0.0 112.289 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.436 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.6 pm0 -70.55 -34.11 71.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.539 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.436 HG13 ' OE2' ' X' ' 14' ' ' GLU . 42.0 mt -68.75 -38.29 78.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.852 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' X' ' 20' ' ' ALA . 1.7 p -158.17 -44.56 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.405 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' X' ' 13' ' ' PRO . . . 81.1 -34.32 2.4 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.411 -0.899 . . . . 0.0 114.375 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.98 110.92 0.43 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.454 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 62.56 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.35 1.06 . . . . 0.0 113.476 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' X' ' 16' ' ' CYS . . . 69.24 -45.77 0.56 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.674 0.789 . . . . 0.0 112.082 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.16 44.28 5.08 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.83 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.452 ' C ' ' H ' ' X' ' 4' ' ' SER . 66.6 m-70 -151.81 38.97 0.61 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.479 0.18 . . . . 0.0 110.609 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 58.5 m -72.77 22.2 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.887 0.375 . . . . 0.0 111.734 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . 0.452 ' H ' ' C ' ' X' ' 2' ' ' HIS . 4.9 m -79.05 -41.54 28.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.897 0.379 . . . . 0.0 110.909 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 35.6 t70 -80.7 127.37 75.53 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.188 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 37.7 Cg_exo -61.07 -37.1 78.31 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.11 2.54 . . . . 0.0 112.501 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . 0.526 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 77.5 mtm180 -66.27 -49.38 67.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.389 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.85 -39.86 72.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -61.58 -40.27 94.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -78.99 -40.73 30.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.141 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.63 -42.95 85.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.296 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -133.04 71.04 78.17 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.64 -30.13 60.39 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.681 2.254 . . . . 0.0 111.631 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -64.74 -39.05 92.98 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.418 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.73 -43.22 86.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.155 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.66 -43.89 95.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.47 -43.93 95.97 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.863 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -32.86 85.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.277 -0.487 . . . . 0.0 112.067 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.71 -3.83 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.5 12.06 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.597 0.56 . . . . 0.0 111.41 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.38 43.73 30.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.999 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.727 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' X' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 112.276 -0.329 . . . . 0.0 112.276 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -81.96 23.84 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.39 0.614 . . . . 0.0 109.912 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.658 ' HB3' ' HA ' ' X' ' 20' ' ' ALA . 2.8 m -63.64 -21.44 66.37 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.049 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 32.8 t -60.82 -24.65 66.02 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.072 0.463 . . . . 0.0 110.356 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.4 t0 -79.68 113.75 40.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.442 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 17.8 Cg_endo -60.29 -31.38 92.83 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.968 2.445 . . . . 0.0 111.984 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 26.6 ttp85 -68.56 -38.37 80.69 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.664 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 23.4 t80 -65.73 -30.11 70.73 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.36 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -65.21 -30.06 70.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.869 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -86.14 -44.78 11.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.578 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 15.1 p-10 -77.26 -22.24 52.45 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -142.26 64.63 17.06 Favored Pre-proline 0 C--O 1.236 0.371 0 CA-C-O 120.994 0.426 . . . . 0.0 111.941 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.52 ' HA ' ' HA3' ' X' ' 17' ' ' GLY . 40.7 Cg_endo -66.89 -26.83 44.02 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.614 2.209 . . . . 0.0 111.997 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 16.4 pm0 -67.47 -35.45 79.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.12 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 57.3 mt -68.32 -53.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.634 0.254 . . . . 0.0 110.73 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' X' ' 19' ' ' ALA . 25.9 p -171.46 46.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.872 0.367 . . . . 0.0 111.204 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' X' ' 13' ' ' PRO . . . -66.98 -51.29 40.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.187 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.23 -46.61 7.45 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' X' ' 16' ' ' CYS . . . -85.92 65.09 8.95 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' X' ' 3' ' ' CYS . . . -68.94 67.35 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.603 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 48.44 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.53 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.695 -179.883 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.272 0 CA-C-O 120.776 0.098 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -118.52 32.21 6.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.174 0.511 . . . . 0.0 109.78 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 35.1 t -69.55 -11.53 60.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -71.46 -20.11 62.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.983 0.421 . . . . 0.0 111.004 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.09 118.76 73.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.724 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -34.08 78.28 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.779 2.319 . . . . 0.0 112.024 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -69.84 -42.56 73.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.439 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -59.87 -42.51 93.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.649 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -67.14 -31.46 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.14 -45.58 55.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.6 -39.95 64.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.716 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -140.27 72.91 31.95 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.7 -27.43 68.59 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.557 2.171 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -54.28 -40.56 67.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.952 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.862 ' HA ' ' HB3' ' X' ' 19' ' ' ALA . 61.5 mt -61.08 -48.61 88.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 29.7 t -77.51 -36.22 52.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.455 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -45.0 96.58 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.915 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.92 64.07 0.17 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.241 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . 0.862 ' HB3' ' HA ' ' X' ' 15' ' ' ILE . . . -153.57 -43.69 0.09 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.534 0.206 . . . . 0.0 110.625 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.89 38.17 21.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.364 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . 0.458 ' H ' HG23 ' X' ' 15' ' ' ILE . . . -67.69 -29.43 73.84 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.355 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.736 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.67 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.752 0 CA-C-O 120.998 0.221 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -158.72 35.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.8 m -61.17 -18.12 56.53 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.858 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -62.02 -26.76 68.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.571 0.7 . . . . 0.0 109.829 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 61.8 t0 -97.05 124.19 50.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.998 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.504 ' HA ' HD22 ' X' ' 9' ' ' ASN . 16.6 Cg_endo -56.64 -29.32 79.11 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.379 2.719 . . . . 0.0 112.549 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.4 -46.57 85.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.416 ' HZ ' HD12 ' X' ' 15' ' ' ILE . 51.2 t80 -65.33 -33.3 75.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.048 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' X' ' 6' ' ' PRO . 50.2 m-80 -60.39 -34.86 74.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.62 -40.68 25.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.068 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -63.94 -52.3 60.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.611 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -136.34 74.36 54.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.835 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.39 -13.26 39.14 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.704 2.27 . . . . 0.0 111.31 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.88 -49.0 79.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.797 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 1.001 ' HA ' ' HB3' ' X' ' 19' ' ' ALA . 62.5 mt -65.13 -49.29 80.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 111.444 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.14 -30.62 69.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.277 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.63 -46.62 38.33 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.681 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.83 48.65 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.793 -1.194 . . . . 0.0 113.398 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . 1.001 ' HB3' ' HA ' ' X' ' 15' ' ' ILE . . . -150.65 49.24 0.87 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.418 0.627 . . . . 0.0 109.762 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.39 129.86 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.375 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.28 -45.14 0.2 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.546 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -150.06 29.33 0.73 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.424 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 20.2 m -79.48 30.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.759 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.7 m -78.29 -33.77 49.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.404 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 7.4 t70 -74.44 123.34 89.05 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.472 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 16.0 Cg_endo -58.62 -39.57 81.52 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.013 2.475 . . . . 0.0 112.62 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -67.94 -40.49 83.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.511 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -55.85 -40.64 73.17 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.303 0.377 . . . . 0.0 111.367 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.556 ' O ' ' HA2' ' X' ' 17' ' ' GLY . 61.1 m-80 -59.13 -42.46 90.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -78.91 -36.91 41.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.657 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.46 -38.1 79.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.974 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -131.78 81.21 63.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.27 0.557 . . . . 0.0 111.721 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.642 ' HA ' ' CA ' ' X' ' 17' ' ' GLY . 30.1 Cg_endo -63.13 -26.62 72.95 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.088 2.525 . . . . 0.0 112.021 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.482 ' HG2' HG13 ' X' ' 15' ' ' ILE . 14.1 pm0 -66.58 -34.41 77.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.279 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.482 HG13 ' HG2' ' X' ' 14' ' ' GLU . 66.9 mt -84.09 -48.47 16.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.9 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' X' ' 20' ' ' ALA . 3.6 p -167.37 66.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.257 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . 0.642 ' CA ' ' HA ' ' X' ' 13' ' ' PRO . . . -72.63 55.81 1.67 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.293 -0.479 . . . . 0.0 113.538 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.39 -49.08 0.46 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.145 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.13 166.15 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' X' ' 16' ' ' CYS . . . -165.79 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.53 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.31 34.33 41.19 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.054 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.753 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -151.61 42.73 0.73 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.951 0.405 . . . . 0.0 110.025 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.421 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 60.1 m -77.88 41.1 0.34 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.225 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.9 p -80.9 -38.04 28.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.395 0.617 . . . . 0.0 109.678 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -84.95 135.26 40.0 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.997 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.62 -33.31 86.59 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.409 2.74 . . . . 0.0 113.569 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -67.23 -50.07 62.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.475 0.179 . . . . 0.0 110.785 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -52.87 -36.38 59.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.345 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 39.6 m-80 -61.71 -37.54 84.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.994 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.528 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 30.0 t80 -82.84 -40.11 20.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.418 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -63.07 -33.59 75.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.468 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -139.55 70.65 38.35 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.958 0.409 . . . . 0.0 111.535 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 36.6 Cg_endo -65.21 -27.12 56.48 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.717 2.278 . . . . 0.0 112.351 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -66.22 -38.36 87.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.602 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 68.4 mt -73.8 -47.85 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 0.0 110.43 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 58.1 m -66.45 -38.98 88.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.998 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.64 -42.8 7.61 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.436 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.4 -52.05 6.31 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.841 -178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.13 -49.33 6.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.838 0.319 . . . . 0.0 111.438 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.53 -75.29 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.429 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.34 47.72 3.8 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.051 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.584 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.866 -179.598 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.894 -0.483 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' X' ' 4' ' ' SER . 31.6 t-80 -153.13 38.84 0.51 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m -77.71 29.63 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.995 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . 0.401 ' H ' ' C ' ' X' ' 2' ' ' HIS . 7.9 m -77.68 -39.54 44.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' X' ' 5' ' ' ASP . 0.0 OUTLIER -72.99 128.26 88.21 Favored Pre-proline 0 N--CA 1.447 -0.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.882 179.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.61 -27.58 85.31 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.065 1.843 . . . . 0.0 110.001 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . 0.599 ' HG2' ' OD2' ' X' ' 11' ' ' ASP . 32.0 ttp85 -66.61 -50.71 62.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.557 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -58.29 -36.63 73.6 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.409 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -59.91 -34.28 72.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.006 0.431 . . . . 0.0 110.378 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -82.62 -42.92 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.493 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' X' ' 7' ' ' ARG . 70.1 m-20 -62.46 -35.5 79.49 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.503 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -141.81 73.96 22.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.018 0.437 . . . . 0.0 112.178 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.33 -33.38 48.25 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.672 2.248 . . . . 0.0 112.161 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.448 ' OE2' HG13 ' X' ' 15' ' ' ILE . 1.5 pm0 -66.84 -40.09 87.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.058 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.448 HG13 ' OE2' ' X' ' 14' ' ' GLU . 62.7 mt -65.1 -48.18 84.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 121.11 0.481 . . . . 0.0 110.07 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 84.9 m -64.3 -42.11 96.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.75 -42.37 93.17 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.362 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.15 -43.6 89.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.728 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.72 -44.25 67.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 56.74 25.78 10.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.229 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.45 52.77 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.775 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.587 179.692 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 112.0 -0.44 . . . . 0.0 112.0 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' X' ' 5' ' ' ASP . 14.3 t-160 -81.55 44.35 0.8 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.742 0.305 . . . . 0.0 110.702 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 40.0 m -63.95 -16.86 62.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.366 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.2 p -67.84 -23.31 65.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.567 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.425 ' HB2' ' NE2' ' X' ' 2' ' ' HIS . 7.4 t0 -87.79 122.81 70.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.908 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.8 -31.8 95.86 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.859 2.373 . . . . 0.0 112.387 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -70.48 -49.06 52.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.282 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.84 -38.21 64.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.832 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -62.78 -33.48 75.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 29.4 t80 -84.68 -43.51 14.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.372 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.02 -36.07 82.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.349 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -143.76 72.43 17.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 40.3 Cg_endo -67.22 -25.36 43.09 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.901 2.4 . . . . 0.0 112.656 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -68.25 -31.39 70.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.504 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.29 -53.28 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.758 ' HA ' ' HA3' ' X' ' 21' ' ' GLY . 62.5 m -79.47 -36.39 38.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.97 -53.72 2.16 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.375 -0.44 . . . . 0.0 112.918 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.41 -39.64 0.14 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.36 141.73 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.96 39.35 20.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.826 0.704 . . . . 0.0 111.728 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' X' ' 16' ' ' CYS . . . -69.96 -29.48 70.76 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.487 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.409 179.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-O 120.89 0.161 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -74.21 44.87 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.758 0.423 . . . . 0.0 111.333 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 66.1 m -66.8 -12.21 58.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.886 0.374 . . . . 0.0 111.72 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -69.11 -23.05 63.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.342 0.591 . . . . 0.0 109.654 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 53.0 t0 -92.02 120.96 67.6 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.265 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 12.0 Cg_endo -56.15 -30.27 78.73 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.173 2.582 . . . . 0.0 112.665 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.91 -48.47 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.015 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.63 -34.27 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.067 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.43 HD22 ' HA ' ' X' ' 6' ' ' PRO . 65.7 m-80 -63.73 -37.39 87.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 110.319 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.41 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 31.0 t80 -79.1 -45.0 20.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.054 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.19 -32.18 72.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -140.71 76.25 24.23 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.198 0.523 . . . . 0.0 111.901 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 42.7 Cg_endo -67.81 -27.76 37.21 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.976 2.451 . . . . 0.0 112.436 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.91 -45.93 55.45 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.435 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.588 HG22 ' HA2' ' X' ' 22' ' ' GLY . 34.1 mt -61.08 -56.18 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.563 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 91.0 m -72.38 -32.59 66.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.811 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.12 -38.93 96.66 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.855 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.04 -23.25 78.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.2 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.9 -49.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.889 0.875 . . . . 0.0 111.889 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 119.03 13.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.124 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.61 40.25 47.06 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.055 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' X' ' 15' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.414 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.505 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -162.24 41.3 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 37.3 m -73.17 44.94 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.405 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -84.7 -38.81 19.29 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.422 ' OD2' ' HB2' ' X' ' 7' ' ' ARG . 17.5 t70 -81.37 137.23 48.71 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.349 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' X' ' 5' ' ' ASP . 32.4 Cg_exo -58.84 -31.71 95.81 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.005 2.47 . . . . 0.0 113.117 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . 0.422 ' HB2' ' OD2' ' X' ' 5' ' ' ASP . 80.2 mtm180 -67.61 -50.65 57.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.501 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.417 ' HA ' ' OD2' ' X' ' 11' ' ' ASP . 7.4 t80 -55.12 -36.38 65.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.575 0.547 . . . . 0.0 111.012 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' X' ' 3' ' ' CYS . 41.0 m-80 -65.69 -28.2 68.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.92 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . 0.402 ' O ' ' HD3' ' X' ' 13' ' ' PRO . 27.9 t80 -90.01 -42.62 11.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.973 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' X' ' 8' ' ' PHE . 2.8 p30 -75.1 -25.2 58.35 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -139.6 63.34 26.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 120.979 0.418 . . . . 0.0 111.66 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' X' ' 10' ' ' TYR . 41.9 Cg_endo -67.06 -27.45 42.21 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.661 2.241 . . . . 0.0 112.328 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -64.43 -36.6 84.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 58.6 mt -68.57 -47.73 75.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.017 0.437 . . . . 0.0 110.149 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 m -64.55 -41.87 96.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.265 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.5 -41.13 58.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.695 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.87 57.29 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.786 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . 54.12 38.08 28.37 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.997 0.427 . . . . 0.0 111.532 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.26 73.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.646 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.66 45.68 0.59 Allowed Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.588 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.803 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' X' ' 5' ' ' ASP . 21.2 t-80 -169.55 34.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.473 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.42 -12.39 61.09 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.389 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -65.0 -25.56 67.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.093 0.473 . . . . 0.0 110.329 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' X' ' 8' ' ' PHE . 22.6 t0 -74.99 114.11 31.57 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.524 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 19.1 Cg_endo -60.92 -35.28 88.88 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.742 2.295 . . . . 0.0 111.802 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . 0.412 ' HB3' ' OD1' ' X' ' 5' ' ' ASP . 22.6 ttp85 -72.6 -41.52 65.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.403 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' X' ' 11' ' ' ASP . 38.2 t80 -58.95 -35.78 73.7 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.456 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -59.96 -36.42 77.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -83.08 -36.29 25.01 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' X' ' 8' ' ' PHE . 52.0 t0 -59.21 -49.3 78.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.793 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -140.06 74.22 31.27 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.212 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.43 -8.78 21.77 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.047 2.498 . . . . 0.0 111.63 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.403 ' HG3' HG13 ' X' ' 15' ' ' ILE . 8.3 pt-20 -65.27 -39.93 93.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.943 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' X' ' 14' ' ' GLU . 59.8 mt -79.64 -59.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.165 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.722 ' HA ' ' HA ' ' X' ' 20' ' ' ALA . 58.2 m -84.28 15.49 3.56 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.12 -46.02 5.73 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.83 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 42.69 0.97 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.235 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -168.05 -50.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' X' ' 16' ' ' CYS . . . 68.93 -63.03 0.38 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.77 -32.44 1.04 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.691 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' X' ' 20' ' ' ALA . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.404 0 N-CA-C 112.309 -0.316 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' X' ' 5' ' ' ASP . 16.5 t-160 -79.86 19.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 122.508 -0.407 . . . . 0.0 110.209 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 22.3 m -66.44 -17.81 65.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.776 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -69.4 -18.08 63.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.087 0.47 . . . . 0.0 110.215 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.486 ' HB2' ' CD2' ' X' ' 2' ' ' HIS . 7.1 t0 -88.72 120.68 70.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.234 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.04 -31.29 93.24 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.328 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -70.75 -44.61 66.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.265 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' OD1' ' X' ' 11' ' ' ASP . 41.5 t80 -59.6 -38.23 80.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.244 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -67.27 -22.07 65.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.682 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -90.96 -44.0 9.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.618 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' X' ' 8' ' ' PHE . 0.5 OUTLIER -80.42 -31.76 37.54 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -178.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -139.14 60.23 16.99 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.65 -24.3 69.53 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.402 2.068 . . . . 0.0 110.728 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.15 -44.3 74.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.184 -1.371 . . . . 0.0 112.156 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.57 -57.46 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.901 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 77.2 m -63.63 -35.61 81.1 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.83 -40.37 64.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.51 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.6 -53.14 6.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.876 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -170.84 124.11 0.64 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.86 -46.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.452 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.18 -56.35 3.62 Favored Glycine 0 CA--C 1.519 0.291 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.824 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.132 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.387 0 N-CA-C 111.932 -0.467 . . . . 0.0 111.932 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.85 30.78 0.08 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' OD1' ' X' ' 9' ' ' ASN . 78.6 m -81.31 44.07 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.346 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 24.4 t -80.16 -34.19 37.81 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 63.7 t0 -81.07 123.24 82.06 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.76 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' X' ' 5' ' ' ASP . 14.5 Cg_endo -57.19 -30.61 87.87 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.986 2.458 . . . . 0.0 112.121 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -66.03 -44.71 83.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -61.98 -37.08 83.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.297 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.562 ' HA ' ' SG ' ' X' ' 16' ' ' CYS . 44.0 m-80 -60.71 -39.58 89.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.643 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -77.92 -41.87 35.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.604 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.23 -40.44 97.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.141 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -130.14 77.08 77.03 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.214 0.531 . . . . 0.0 111.99 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.38 -21.89 34.6 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.885 2.39 . . . . 0.0 112.029 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.464 ' OE1' HG13 ' X' ' 15' ' ' ILE . 0.0 OUTLIER -72.21 -47.95 46.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.471 179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.464 HG13 ' OE1' ' X' ' 14' ' ' GLU . 37.2 mt -67.42 -48.28 77.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.459 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' X' ' 9' ' ' ASN . 77.2 m -66.56 -36.68 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.34 44.31 2.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.939 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.59 -46.13 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.61 53.8 1.38 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 111.032 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.24 131.44 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.95 32.84 60.38 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.178 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.784 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.799 179.755 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -76.91 49.55 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 95.6 m -73.83 50.11 0.34 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.786 0.803 . . . . 0.0 112.092 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -116.86 -37.96 3.52 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.01 135.91 89.58 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.73 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.94 -40.36 85.5 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.572 2.182 . . . . 0.0 112.069 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 53.7 mmm-85 -71.35 -40.88 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.504 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' X' ' 12' ' ' HIS . 6.7 t80 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.126 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -76.16 -46.5 28.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.957 0.408 . . . . 0.0 111.425 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -74.27 -58.79 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.29 9.89 1.86 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' X' ' 8' ' ' PHE . 8.8 m80 -145.03 64.36 11.01 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.802 0.334 . . . . 0.0 110.296 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.5 -32.9 58.8 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.547 2.164 . . . . 0.0 112.456 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' X' ' 14' ' ' GLU . 0.4 OUTLIER -70.52 -41.93 71.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.708 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . 0.483 HG13 ' OE2' ' X' ' 14' ' ' GLU . 70.5 mt -67.52 -54.79 20.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 111.239 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m -69.82 -38.46 76.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.441 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.03 46.35 3.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.259 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.87 -56.21 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.741 -0.543 . . . . 0.0 111.741 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.29 -47.36 13.45 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.02 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.387 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.88 -37.59 50.5 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.915 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.347 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 121.151 0.306 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' X' X ' 2' ' ' HIS . . . . . 0.496 ' HB3' ' CD2' ' X' ' 8' ' ' PHE . 20.4 t-160 -77.46 40.16 0.28 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 122.33 -0.512 . . . . 0.0 110.529 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 3' ' ' CYS . . . . . . . . . . . . . 28.6 m -68.39 -14.65 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.409 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 4' ' ' SER . . . . . . . . . . . . . 34.9 t -62.91 -25.18 68.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.337 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 5' ' ' ASP . . . . . 0.454 ' HA ' ' HD2' ' X' ' 6' ' ' PRO . 65.6 t0 -92.1 113.54 59.38 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 6' ' ' PRO . . . . . 0.469 ' HA ' HD22 ' X' ' 9' ' ' ASN . 13.9 Cg_endo -57.77 -36.48 98.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.078 2.519 . . . . 0.0 112.114 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -67.07 -44.02 81.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.35 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 8' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' X' ' 2' ' ' HIS . 71.2 t80 -61.5 -36.38 80.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.293 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 9' ' ' ASN . . . . . 0.469 HD22 ' HA ' ' X' ' 6' ' ' PRO . 78.7 m-20 -60.34 -36.77 78.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.006 0.431 . . . . 0.0 110.82 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 10' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -82.15 -41.17 20.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.458 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 11' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.1 -42.79 79.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.339 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 12' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -145.71 74.21 13.64 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 13' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.94 -30.35 67.23 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.753 2.302 . . . . 0.0 112.203 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 14' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 -65.59 -39.18 91.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.654 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 15' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.65 -34.58 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 16' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -63.03 -45.68 91.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.717 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' X' X ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.79 62.13 3.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.984 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.44 -41.6 93.38 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 121.244 -0.503 . . . . 0.0 112.637 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.16 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.144 0.497 . . . . 0.0 110.474 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.62 118.9 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.823 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.74 -64.17 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.729 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' X' X ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.75 179.428 . . . . . . . . 0 0 . 1 stop_ save_